Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Solomon

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Nature Communications|May 16, 2018
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinomaJeffrey P North, Justin Golovato, Charles J Vaske, et al.
Ophthalmology|March 7, 2020
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic FeaturesArmin R Afshar, Melike Pekmezci, Michele M Bloomer, et al.
Brain Pathology (Zurich, Switzerland)|November 13, 2018
Clinicopathologic features of anaplastic myxopapillary ependymomasJulieann C Lee, Nima Sharifai, Sonika Dahiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Acta Neuropathologica|June 27, 2022
Intratumor and informatic heterogeneity influence meningioma molecular classificationHarish N Vasudevan, Abrar Choudhury, Stephanie Hilz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF<sup>V600E</sup>-Mutant Human GliomaKarisa C Schreck, Andrew Morin, Guisheng Zhao, et al.
Neurosurgery|April 22, 2021
Letter: Patterns of Intermediate- and High-Risk Meningioma Recurrence After Treatment With Postoperative External Beam RadiotherapyMatthew S Susko, William C Chen, Harish N Vasudevan, et al.
Acta Neuropathologica|July 29, 2021
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'Rohit Gupta, Calixto-Hope G Lucas, Jasper Wu, et al.
Acta Neuropathologica|February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activationJ Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Nature Communications|May 16, 2018
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinomaJeffrey P North, Justin Golovato, Charles J Vaske, et al.
Ophthalmology|March 7, 2020
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic FeaturesArmin R Afshar, Melike Pekmezci, Michele M Bloomer, et al.
Brain Pathology (Zurich, Switzerland)|November 13, 2018
Clinicopathologic features of anaplastic myxopapillary ependymomasJulieann C Lee, Nima Sharifai, Sonika Dahiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Acta Neuropathologica|June 27, 2022
Intratumor and informatic heterogeneity influence meningioma molecular classificationHarish N Vasudevan, Abrar Choudhury, Stephanie Hilz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF<sup>V600E</sup>-Mutant Human GliomaKarisa C Schreck, Andrew Morin, Guisheng Zhao, et al.
Neurosurgery|April 22, 2021
Letter: Patterns of Intermediate- and High-Risk Meningioma Recurrence After Treatment With Postoperative External Beam RadiotherapyMatthew S Susko, William C Chen, Harish N Vasudevan, et al.
Acta Neuropathologica|July 29, 2021
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'Rohit Gupta, Calixto-Hope G Lucas, Jasper Wu, et al.
Acta Neuropathologica|February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activationJ Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
Pageof 21